BB-1705

· Bliss Biopharmaceutical (Hangzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BB-1705, covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors [Phase 1]

See pricing